Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (sign... حسب Mobina Faqani (22783963)

Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “... حسب Mobina Faqani (22783963)

IRE1 depletion decreases heterochromatin, DNA, and H3K9me3 methylation, and UHRF1. حسب Iratxe Zuazo-Gaztelu (21071939)

Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. حسب Cristina Dolciotti (16317330)

EGFR/ERK signaling activity decreases throughout LEC elimination with endocytic activity dependency. حسب Kevin Yuswan (19845885)

Middle cerebral artery mean flow velocity at three time points. حسب Marco Carbonara (11483575)

الموضوعات:

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. حسب Katherine Schubert (5452712)

The mean and standard deviation of parameters. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

B2 decreases glycolytic intermediates in cells. حسب Craig Eyster (392633)

"…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …"

Reducing Dscam1 diversity decreases adult lifespan in an exon-specific manner, Related to Fig 3. حسب Haiyang Dong (4783608)

Reducing Dscam1 diversity decreases adult lifespan in a cluster-specific manner, also see S6 and S7 Figs. حسب Haiyang Dong (4783608)

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from off-label medications clinical trials. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. حسب Filip Stanicic (17808254)

الموضوعات: